Loading...
XNASCHEK
Market cap8mUSD
Dec 24, Last price  
1.46USD
1D
-35.11%
1Q
3.55%
Jan 2017
-99.74%
IPO
-99.89%
Name

Check Cap Ltd

Chart & Performance

D1W1MN
XNAS:CHEK chart
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
95.86%
Rev. gr., 5y
%
Revenues
0k
00-788,000173,000244,0000000000
Net income
-18m
L-8.76%
-3,721,000-3,995,000-4,076,000-12,290,000-8,826,000-9,771,000-10,589,000-13,596,000-13,761,000-17,092,000-19,254,000-17,568,000
CFO
-17m
L-9.37%
-4,160,000-3,657,000-4,541,000-8,628,000-7,923,000-9,150,000-10,034,000-12,843,000-13,113,000-16,264,000-18,707,000-16,954,000
Earnings
May 13, 2025

Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
URL
https://check-cap.com/
IPO date
Feb 19, 2015
Employees
85
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
Cost of revenue
18,056
20,439
17,526
Unusual Expense (Income)
NOPBT
(18,056)
(20,439)
(17,526)
NOPBT Margin
Operating Taxes
146
(110)
Tax Rate
NOPAT
(18,056)
(20,585)
(17,416)
Net income
(17,568)
-8.76%
(19,254)
12.65%
(17,092)
24.21%
Dividends
Dividend yield
Proceeds from repurchase of equity
8,850
51,024
BB yield
-70.93%
-91.33%
Debt
Debt current
337
350
Long-term debt
1,591
1,940
Deferred revenue
Other long-term liabilities
94
132
Net debt
(24,756)
(39,771)
(49,271)
Cash flow
Cash from operating activities
(16,954)
(18,707)
(16,264)
CAPEX
(83)
(486)
(1,006)
Cash from investing activities
21,356
(12,508)
(16,006)
Cash from financing activities
8,850
51
FCF
(15,406)
(20,487)
(19,104)
Balance
Cash
24,756
41,699
51,561
Long term investments
Excess cash
24,756
41,699
51,561
Stockholders' equity
(61,115)
(43,629)
(39,398)
Invested Capital
84,802
85,999
91,366
ROIC
ROCE
EV
Common stock shares outstanding
5,849
5,672
4,140
Price
2.08
-5.45%
2.20
-83.70%
13.49
46.67%
Market cap
12,165
-2.50%
12,478
-77.67%
55,870
300.17%
EV
(12,591)
(27,293)
6,599
EBITDA
(17,844)
(20,035)
(17,321)
EV/EBITDA
0.71
1.36
Interest
13
12
13
Interest/NOPBT